Clinical Trial Update: A Study of Local Administration of Autologous Mesenchymal Stromal Cells in Dysphonic Patients With Vocal Fold Scarring [Phase 1, Phase 2]

View source ↗

Summary

A completed Phase 1/2 study evaluated local administration of autologous mesenchymal stromal cells for vocal fold scarring in patients with hoarseness and dysph…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aphonia
• Dysphonia
• Hoarseness
• Vocal Fold Scar

Drugs mentioned

• Autologous mesenchymal stromal cell therapy (local administration) (Mesenchymal stromal cells)

Snippet

Sponsor: Karolinska University Hospital | Conditions: Hoarseness, Dysphonia | Phase 1, Phase 2 | Status: COMPLETED